These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 9627703)
21. Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines. Lee DW; Park SW; Park SY; Heo DS; Kim KH; Sung MW Head Neck; 2004 Aug; 26(8):706-15. PubMed ID: 15287038 [TBL] [Abstract][Full Text] [Related]
22. Protein p53--structure, function, and possible therapeutic implications. Batinac T; Gruber F; Lipozencić J; Zamolo-Koncar G; Stasić A; Brajac I Acta Dermatovenerol Croat; 2003 Dec; 11(4):225-30. PubMed ID: 14670223 [TBL] [Abstract][Full Text] [Related]
23. Molecular epidemiology of human cancer risk: gene-environment interactions and p53 mutation spectrum in human lung cancer. Bennett WP; Hussain SP; Vahakangas KH; Khan MA; Shields PG; Harris CC J Pathol; 1999 Jan; 187(1):8-18. PubMed ID: 10341702 [TBL] [Abstract][Full Text] [Related]
24. The p53 network in lung carcinogenesis. Robles AI; Linke SP; Harris CC Oncogene; 2002 Oct; 21(45):6898-907. PubMed ID: 12362272 [TBL] [Abstract][Full Text] [Related]
25. Life and death by p53. Elledge RM; Lee WH Bioessays; 1995 Nov; 17(11):923-30. PubMed ID: 8526886 [TBL] [Abstract][Full Text] [Related]
26. TP53 tumour suppressor gene: clues to molecular carcinogenesis and cancer therapy. Wang XW; Harris CC Cancer Surv; 1996; 28():169-96. PubMed ID: 8977035 [TBL] [Abstract][Full Text] [Related]
27. [RB and P53 tumor suppressor genes]. May P Bull Cancer; 1993 Aug; 80(8):690-2. PubMed ID: 8204949 [No Abstract] [Full Text] [Related]
28. Genetic tumor archeology: microdissection and genetic heterogeneity in squamous and basal cell carcinoma. Bäckvall H; Asplund A; Gustafsson A; Sivertsson A; Lundeberg J; Ponten F Mutat Res; 2005 Apr; 571(1-2):65-79. PubMed ID: 15748639 [TBL] [Abstract][Full Text] [Related]
29. Roles of the transcription factor p53 in keratinocyte carcinomas. Brash DE Br J Dermatol; 2006 May; 154 Suppl 1():8-10. PubMed ID: 16712710 [TBL] [Abstract][Full Text] [Related]
31. Mutations and polymorphisms in the p53, p21 and p16 genes in oral carcinomas of Indian betel quid chewers. Heinzel PA; Balaram P; Bernard HU Int J Cancer; 1996 Nov; 68(4):420-3. PubMed ID: 8945609 [TBL] [Abstract][Full Text] [Related]
32. Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. Ambs S; Hussain SP; Harris CC FASEB J; 1997 May; 11(6):443-8. PubMed ID: 9194524 [TBL] [Abstract][Full Text] [Related]
33. [p53 as a molecular target for cancer therapy]. Ishioka C; Osada M; Gamo M; Kanamaru R Gan To Kagaku Ryoho; 1997 Dec; 24(15):2207-12. PubMed ID: 9422063 [TBL] [Abstract][Full Text] [Related]
34. [Mutations of the p53 gene in hematologic neoplasms]. Mori N; Mizoguchi H Nihon Rinsho; 1992 Jun; 50(6):1353-7. PubMed ID: 1518157 [TBL] [Abstract][Full Text] [Related]
35. p53 mutation heterogeneity in cancer. Soussi T; Lozano G Biochem Biophys Res Commun; 2005 Jun; 331(3):834-42. PubMed ID: 15865939 [TBL] [Abstract][Full Text] [Related]
36. [Protein P53, protector of genome integrity: its role in carcinogenesis]. Bellahcene A; Merville MP; Gielen J; Lambotte R; Simar L; Castronovo V Rev Med Liege; 1994 May; 49(5):274-84. PubMed ID: 8023054 [No Abstract] [Full Text] [Related]
37. [Tumor suppressor genes: mutations in RB and p53 genes are significant carcinogenic factors]. Wiman KG Lakartidningen; 1992 Sep; 89(39):3169-74. PubMed ID: 1405928 [TBL] [Abstract][Full Text] [Related]
38. Molecular basis of multistage carcinogenesis. Harris CC Princess Takamatsu Symp; 1991; 22():3-19. PubMed ID: 1844248 [TBL] [Abstract][Full Text] [Related]
39. p53 protects against skin cancer induction by UV-B radiation. Jiang W; Ananthaswamy HN; Muller HK; Kripke ML Oncogene; 1999 Jul; 18(29):4247-53. PubMed ID: 10435637 [TBL] [Abstract][Full Text] [Related]